TY - JOUR AU - Taylor Colman AU - Seppelt I. AU - Glass Parisa AU - Eastwood G. AU - Rajbhandari D. AU - Myburgh J AU - Hammond N. AU - Thompson Kelly AU - Festa M. AU - Watts N. AB -

BACKGROUND: Cross-sectional point prevalence studies collect observational data at a single time point and may be used to facilitate subsequent research hypotheses and discovery. METHODS: We report the process of implementation and substantive outputs of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS CTG) point prevalence program, conducted in participating intensive care units from 2009 to 2016. RESULTS: Seventy-seven of a maximum 197 adult ICUs across Australia and New Zealand participated in 9 specified study days over 18 days of data collection and collected data on 5043 participants, with an average of 44 ICUs per study day. All eight Australian and New Zealand paediatric ICUs have participated in dedicated simultaneous paediatric study days. Thirteen manuscripts were published in peer-reviewed journals and data have contributed to 14 individual programs of research, including 18 subsequent grant applications for further research. CONCLUSION: The ANZICS CTG point prevalence program has resulted in the collection of a substantial body of observational data that has facilitated the development and completion of subsequent research programs and provided opportunities for subsequent capacity development.

AD - Critical Care and Trauma Division, The George Institute for Global Health, Sydney, NSW, Australia.
Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.
ANZICS Clinical Trials Group, Melbourne, VIC, Australia. AN - 28215137 BT - Crit Care ResuscCritical Care and Resuscitation DP - NLM ET - 2017/02/22 J2 - Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine LA - eng LB - AUS
CCT
FY17 M1 - 1 N1 - Thompson, Kelly
Hammond, Naomi
Eastwood, Glenn
Festa, Marino
Glass, Parisa
Rajbhandari, Dorrilyn
Seppelt, Ian
Taylor, Colman
Watts, Nicola
Myburgh, John
The Point Prevalence Program Management Committee
The Australian and New Zealand Intensive Care Society Clinical Trials Group
The George Institute for Global Health
Australia
Crit Care Resusc. 2017 Mar;19(1):88-93. N2 -

BACKGROUND: Cross-sectional point prevalence studies collect observational data at a single time point and may be used to facilitate subsequent research hypotheses and discovery. METHODS: We report the process of implementation and substantive outputs of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS CTG) point prevalence program, conducted in participating intensive care units from 2009 to 2016. RESULTS: Seventy-seven of a maximum 197 adult ICUs across Australia and New Zealand participated in 9 specified study days over 18 days of data collection and collected data on 5043 participants, with an average of 44 ICUs per study day. All eight Australian and New Zealand paediatric ICUs have participated in dedicated simultaneous paediatric study days. Thirteen manuscripts were published in peer-reviewed journals and data have contributed to 14 individual programs of research, including 18 subsequent grant applications for further research. CONCLUSION: The ANZICS CTG point prevalence program has resulted in the collection of a substantial body of observational data that has facilitated the development and completion of subsequent research programs and provided opportunities for subsequent capacity development.

PY - 2017 SN - 1441-2772 (Print)
1441-2772 (Linking) SP - 88 EP - 93 ST - Critical Care and Resuscitation T2 - Crit Care ResuscCritical Care and Resuscitation TI - The Australian and New Zealand Intensive Care Society Clinical Trials Group point prevalence program, 2009-2016 VL - 19 Y2 - FY17 ER -